ArticleThe American journal of case reports2018

Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 Patients.

Erica S Tarabadkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.